(RCUS) Arcus Biosciences - Performance -41.4% in 12m
RCUS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-76.86%
#121 in Peer-Group
Rel. Strength
11.86%
#6796 in Stock-Universe
Total Return 12m
-41.37%
#119 in Peer-Group
Total Return 5y
-64.25%
#74 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 18.44 USD |
| 52 Week Low | 6.87 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 49.83 |
| Buy/Sell Signal +-5 | 1.04 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RCUS (-41.4%) vs XBI (-7.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.11% | 68.3% | 77.5% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.3% | -6.89% | 148% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.9% | -1.4% | 35.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
0.57% | 33% | -5.3% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.89% | -5.88% | 1.36% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.2% | 59.2% | -5.89% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.66% | 61.7% | -9.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.23% | 38.8% | 14.5% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: RCUS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RCUS
| Total Return (including Dividends) | RCUS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -6.83% | 4.38% | 4.99% |
| 3 Months | 8.87% | 5.22% | 10.23% |
| 12 Months | -41.37% | -7.16% | 14.42% |
| 5 Years | -64.25% | -24.61% | 110.17% |
| Trend Score (consistency of price movement) | RCUS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -91.3% | 3.5% | 79.1% |
| 3 Months | 62.2% | 75.7% | 95.5% |
| 12 Months | -78.5% | -85.1% | 44.7% |
| 5 Years | -81.2% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th30.50 | -10.74% | -11.26% |
| 3 Month | %th56.50 | 3.47% | -1.24% |
| 12 Month | %th41.50 | -36.84% | -48.76% |
| 5 Years | %th62.00 | -52.58% | -82.99% |
FAQs
Does Arcus Biosciences (RCUS) outperform the market?
No,
over the last 12 months RCUS made -41.37%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.16%.
Over the last 3 months RCUS made 8.87%, while XBI made 5.22%.
Performance Comparison RCUS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RCUS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.6% | -11.8% | -50% | -56% |
| US NASDAQ 100 | QQQ | -2.1% | -12.2% | -51.5% | -55% |
| German DAX 40 | DAX | -1.6% | -6.3% | -61.5% | -72% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.2% | -11% | -50.4% | -59% |
| Hongkong Hang Seng | HSI | -0.6% | -14% | -68.5% | -78% |
| India NIFTY 50 | INDA | -1.4% | -8.8% | -47.4% | -41% |
| Brasil Bovespa | EWZ | -5.2% | -14.8% | -72.9% | -55% |
RCUS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.5% | -12.5% | -54.3% | -68% |
| Consumer Discretionary | XLY | -3.6% | -9.7% | -43.1% | -60% |
| Consumer Staples | XLP | -2.8% | -6.7% | -49.4% | -51% |
| Energy | XLE | -3.2% | -12.9% | -45.2% | -40% |
| Financial | XLF | -2.7% | -10.4% | -53.2% | -70% |
| Health Care | XLV | -1.4% | -9.3% | -42.5% | -37% |
| Industrial | XLI | -3.4% | -11% | -56.8% | -65% |
| Materials | XLB | -5.7% | -12.6% | -54.2% | -48% |
| Real Estate | XLRE | -1.7% | -7.7% | -48.5% | -54% |
| Technology | XLK | -2.1% | -15.9% | -52.9% | -53% |
| Utilities | XLU | -1.3% | -6.4% | -51.2% | -64% |
| Aerospace & Defense | XAR | -2.8% | -14.4% | -68.3% | -90% |
| Biotech | XBI | -2.2% | -11.2% | -35.9% | -34% |
| Homebuilder | XHB | -7.5% | -18.5% | -44% | -48% |
| Retail | XRT | -5.2% | -12.3% | -44.8% | -52% |
RCUS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -3.5% | -15.5% | -41.5% | -35% |
| Natural Gas | UNG | 2.4% | 1.8% | -33.9% | -35% |
| Gold | GLD | -1% | -6.1% | -69.2% | -85% |
| Silver | SLV | -1.1% | -12.1% | -66.7% | -65% |
| Copper | CPER | -4.8% | -13% | -70.6% | -59% |
RCUS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -0.8% | -10.1% | -45.4% | -42% |
| iShares High Yield Corp. Bond | HYG | -1% | -8.8% | -48.1% | -52% |